在皮肤癌中使用冷等离子体喷射疗法的合理性
Sander Bekeschus1,2, Debora Singer1,2, Gishan Ratnayake3
1Department of Dermatology and Venerology, Rostock University Medical Center, Rostock, Germany.
Experimental dermatology
|February 20, 2025
概括
冷大气等离子体为治疗皮肤癌提供了一个有前途的新途径. 这种利用活性氧和物种的创新疗法显示,它有可能补充各种皮肤瘤的现有治疗方法.
科学领域:
- 皮肤瘤学 皮肤瘤学
- 血医学是一种血医学.
背景情况:
- 全球皮肤癌发病率正在上升,需要新的治疗方法.
- 目前用于皮肤瘤的治疗方法,如基底细胞癌和黑色素瘤,在有效性和耐受性方面存在局限性.
- 冷大气等离子体 (CAP) 是一种新兴技术,在皮肤病学中已证明其安全性和有效性.
研究的目的:
- 审查冷大气等离子体在皮肤癌治疗中的当前应用.
- 概述皮肤瘤学中基于等离子体的治疗方法的作用机制和治疗概念.
- 探索将CAP纳入现有的皮肤癌治疗方案.
主要方法:
- 对皮肤癌冷大气等离子体现有的临床前和临床研究的审查.
- 专注于批准的喷射等离子器件及其在皮肤瘤学中的应用.
- 分析CAP的反应性氧和物种的产生.
主要成果:
- 冷大气等离子体设备在临床试验中已证明安全性,并已被批准用于某些皮肤病症.
- 临床前和早期临床数据表明,CAP在治疗皮肤瘤方面具有重大潜力.
- 喷射等离子技术特别适用于皮肤癌应用.
结论:
- 冷大气等离子体为皮肤癌提供了一个可行的补充治疗策略.
- 进一步的临床研究对于将CAP纳入标准皮肤癌护理至关重要.
- 血医学为推进皮肤瘤学提供了一个有希望的前沿.
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K


